Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study
about
Brain fuel metabolism, aging, and Alzheimer's diseaseAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentMagnesium Status in Alzheimer's Disease: A Systematic ReviewBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialDefining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates.Characterizing blood-brain barrier perturbations after exposure to human triglyceride-rich lipoprotein lipolysis products using MRI in a rat model.Metabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study.Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.Diabetes is associated with increased rate of cognitive decline in questionably demented elderly.Metabolic syndrome is associated with learning and recall impairment in middle age.Metabolic syndrome and localization of white matter hyperintensities in the elderly populationAmyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity.Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.The vascular contribution to Alzheimer's disease.Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial.Metabolic syndrome, brain magnetic resonance imaging, and cognition.Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseaseDiabetes and cognitionModeling metabolic syndrome and its association with cognition: the Northern Manhattan study.Inflammation as a mediator of the relationship between cortical thickness and metabolic syndromeGout and the risk of dementia: a nationwide population-based cohort study.The Postprandial Effects of a Moderately High-Fat Meal on Lipid Profiles and Vascular Inflammation in Alzheimer's Disease Patients: A Pilot Study.Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) StudyEpidemiology of Alzheimer disease.Dyslipidemia and blood-brain barrier integrity in Alzheimer's diseaseBlood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.Cerebral Cortical Microvascular Rarefaction in Metabolic Syndrome is Dependent on Insulin Resistance and Loss of Nitric Oxide Bioavailability.Association between Metabolic Syndrome and Cognitive Impairment after Acute Ischemic Stroke: A Cross-Sectional Study in a Chinese Population.Models and mechanisms of vascular dementia.Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort studyImpact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats.Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysisLate-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women: A Prospective Cohort Study.Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adultsPrescription n-3 fatty acids, but not eicosapentaenoic acid alone, improve reference memory-related learning ability by increasing brain-derived neurotrophic factor levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model.
P2860
Q24625859-6B73A646-D31D-47C2-8E3F-47701672BB10Q26825442-FB8C7472-17EB-492D-9D04-DF21D251FE91Q26860246-42A6043B-53C9-4EA7-9CCF-0FB7BFF9A61BQ28267123-60247FBA-8D2E-4536-9279-6ECCEFFC30E7Q29994589-285652C3-268C-4BAF-A0FC-F68E57608D4BQ30235254-769CF46D-AAEB-48A6-94DC-E62598F991B8Q30239094-16B4A468-4DFF-45C7-B8BA-F77340281D9AQ30488441-6E5453EA-EC8A-458A-A3C6-A1EE9C02A7EAQ33556918-C033BD80-DCA3-416B-A3CD-285A6A98029EQ33607787-A1E46B9D-ECF6-45A7-84F3-4B78562B78E2Q33733475-412BEB61-9D9F-4DA4-A1B5-B8EE7F5CF880Q33928071-5911A4B6-03EA-411A-83C5-D7CDF8252D6BQ33939271-4B0AF966-B13D-491E-BF2F-9F0AF0949A9EQ34140538-006992BE-CB02-4544-8E97-96F1F0D3A6F4Q34154473-98526D5C-00F9-4BE6-9302-12F1D255B68DQ34178526-500FA99D-04FA-41B0-828B-261FA2F6F7A7Q34204718-08DB49AA-6C00-476A-9BB1-7463A299CCE2Q34351623-403CE026-333D-4257-A511-253A3CDD0C71Q34533985-044220A9-4EF4-48DA-B11B-775F5946F692Q35207601-42B7A7F2-A96D-47C5-9BA3-6CE36E647A20Q35234745-A56871F3-60FF-4999-9B2F-15C282E59E5DQ35582644-98D71449-5CD8-4556-86E0-AAAD4E7F26A0Q35658728-A59DCC0F-13E9-4386-B84F-EE625FA770D1Q35665512-468A6974-5DDB-49E7-8E7E-2E8F69871EBBQ35894289-0247E473-36DC-46DF-9B23-41B25D10702DQ35920548-AEADB5DB-548E-4E57-A077-8BB835D5EB42Q35986336-4C971238-B4D4-400E-8F68-7063D5556E3BQ35995579-79771A38-5E33-41BA-88DF-30D94FA91FC2Q36001154-42689124-6DE3-4BEE-A03E-ECB09C6CC3E8Q36218067-36DD926F-5732-4054-81CB-6AAF0C50D877Q36244982-79AFD070-3C05-4B94-A291-16EE31BEDA2BQ36325378-9840B027-1A51-49AD-8BD3-3D12FBEAE262Q36329909-983DBAE1-EEEE-4E01-B1BA-EAD6EA5664F7Q36422434-42882755-E04F-4142-8867-BB15319C2B33Q36457368-1EEAAE81-F309-46FC-B27A-5392A4A07118Q36665446-B4E55874-23E1-4F6A-8E8F-5FE43281D90FQ36807001-50A49521-7AF2-4E11-98AB-50924462AEC6Q36822872-6D1D5502-A406-49F2-856B-15BD7C5E527FQ36880464-E310B311-49DA-42F5-8206-E4A8E324F222Q37187346-9BB403D9-289B-44EE-9A2E-200AEC1B703B
P2860
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic syndrome and risk fo ...... dementia: the Three-City Study
@en
Metabolic syndrome and risk fo ...... ementia: the Three-City Study.
@nl
type
label
Metabolic syndrome and risk fo ...... dementia: the Three-City Study
@en
Metabolic syndrome and risk fo ...... ementia: the Three-City Study.
@nl
prefLabel
Metabolic syndrome and risk fo ...... dementia: the Three-City Study
@en
Metabolic syndrome and risk fo ...... ementia: the Three-City Study.
@nl
P2093
P2860
P921
P356
P1433
P1476
Metabolic syndrome and risk fo ...... dementia: the Three-City Study
@en
P2093
Annick Alpérovitch
Catherine Helmer
Christelle Raffaitin
Claudine Berr
Florence Portet
Jean-François Dartigues
Jean-Philippe Empana
P2860
P304
P356
10.2337/DC08-0272
P407
P577
2008-10-22T00:00:00Z